0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

TREATMENT OF TUBERCULOSIS

KARL H. PFUETZE, M.D.; EUGENE J. DesAUTELS, M.D.
AMA Arch Intern Med. 1956;97(1):99-104. doi:10.1001/archinte.1956.00250190115011.
Text Size: A A A
Published online

DURING the past decade since the advent of streptomycin, changes in the treatment of tuberculosis in its various forms have occurred with almost bewildering rapidity. This period of transition has been marked by considerable difference of opinion as to the antimicrobial regimen of choice, duration of treatment, indications for surgical intervention, etc.* However, there is general agreement that specific antimicrobial therapy is indicated in all forms of active tuberculosis, regardless of the organs or system involved. The treatment of pulmonary tuberculosis will be considered first.

PULMONARY TUBERCULOSIS 

Drug Therapy  The drugs most commonly used today are isoniazid, streptomycin (or dihydrostreptomycin), and sodium aminosalicylate (PAS-sodium). Viomycin is used much less often. Pyrazinamide in combination with isoniazid is another drug combination which may emerge after further investigation as a significant addition to the armamentarium.10

Streptomycin Sulfate.  —This is one of the most effective antimicrobial agents we have for tuberculosis. It should not be used alone because of

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();